Alyeska Investment Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-137,345	Closed	-$584K	–	585
2018 Q2	$584K	Buy	+137,345	New	+$692K	0.01%	419
2017 Q4	–	Sell	-964,116	Closed	-$5.91M	–	585
2017 Q3	$5.91M	Buy	964,116 +91,763	+11%	+$581K	0.05%	281
2017 Q2	$6.31M	Buy	872,353 +722,353	+482%	+$4.44M	0.05%	270
2017 Q1	$795K	Buy	+150,000	New	+$1.01M	0.01%	441
2016 Q3	–	Sell	-1,508,548	Closed	-$9.53M	–	562
2016 Q2	$9.53M	Buy	1,508,548 +258,548	+21%	+$1.66M	0.09%	258
2016 Q1	$6.9M	Buy	1,250,000 +564,448	+82%	+$2.12M	0.06%	266
2015 Q4	$3.83M	Buy	685,552 +123,873	+22%	+$819K	0.04%	273
2015 Q3	$4.75M	Buy	561,679 +418,427	+292%	+$7.08M	0.06%	255
2015 Q2	$2.17M	Buy	143,252 +80,712	+129%	+$1.17M	0.03%	341
2015 Q1	$1M	Sell	62,540 -18,564	-23%	-$330K	0.02%	433
2014 Q4	$1.45M	Sell	81,104 -24,396	-23%	-$304K	0.03%	364
2014 Q3	$1.06M	Buy	105,500 +73,483	+230%	+$891K	0.02%	321
2014 Q2	$500K	Sell	32,017 -48,876	-60%	-$693K	0.01%	379
2014 Q1	$1.5M	Buy	+80,893	New	+$1.62M	0.05%	276